XML 55 R40.htm IDEA: XBRL DOCUMENT v3.22.4
CAPITAL STOCK (Tables)
 12 Months Ended
Dec. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of weighted average valuation assumptions
The fair value of each time vesting option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:
 20212020
Risk-free interest rate0.98%3.64%
Expected lives5.6 years5.3 years
Expected volatility47%46%
Expected dividend yield0%0%
Schedule of stock options plans
A summary of our time vesting stock option activity is as follows:
 Year Ended December 31,
 2022
  OptionsWeighted Average Exercise Price
Outstanding at beginning of period420,202 $64.06 
Granted at market— $— 
Forfeited(7,416)$122.56 
Expired(291)$150.29 
Exercised(72,457)$25.87 
Outstanding at end of period340,038 $70.84 
Exercisable at end of period322,662 $66.18 
Schedule of shares authorized under stock options plans by exercise price range The following table summarizes information about time vesting stock options outstanding and exercisable at December 31, 2022.
Options OutstandingOptions Exercisable
Exercise PricesNumber of
Options
Outstanding
Weighted
Average
Remaining
Contractual
Life in Years		Weighted
Average
Exercise
Price		Number of
Options
Exercisable
Weighted
Average
Remaining
Contractual
Life in Years		Weighted
Average
Exercise
Price
$7.36 - $21.0936,148 1.41$12.49 36,148 1.41$12.49 
$21.10 - $69.7689,717 6.11$54.97 89,717 6.11$54.97 
$69.77 - $71.8380,851 5.33$69.81 80,851 5.33$69.81 
$71.84 - $95.6586,131 5.80$79.59 86,131 5.80$79.59 
$95.66 - $188.6247,191 7.05$131.51 29,815 6.46$116.40 
$7.36 - $188.62340,038 5.48$70.84 322,662 5.34$66.18 
Options OutstandingOptions Exercisable
Exercise PricesNumber of
Options
Outstanding
at
December 31,
2022		Weighted
Average
Remaining
Contractual
Life in Years		Weighted
Average
Outstanding
Price		Number of
Options
Exercisable
at
December 31,
2022		Weighted
Average
Remaining
Contractual
Life in Years		Weighted
Average
Exercise
Price
$60.94210,000 7.29$60.94 93,750 7.29$60.94 
$198.4034,800 3.44$198.40 — — $— 
$60.94 - $198.40244,800 6.75$80.48 93,750 7.29$60.94 
Schedule of restricted stock transactions
A summary of our performance-based stock option activity is as follows:
 Year Ended December 31,
 2022
  OptionsWeighted Average Exercise Price
Outstanding at beginning of period254,800 $79.71 
Granted at market— $— 
Forfeited(5,000)$60.94 
Exercised(5,000)$60.94 
Outstanding at end of period244,800 $80.48 
Exercisable at end of period93,750 $60.94 
The following table summarizes restricted stock transactions for the year ended December 31, 2022:
Restricted Stock AwardsRestricted Stock Units
Restricted StockWeighted-Average Grant Date Fair Value Per AwardRestricted StockWeighted-Average Grant Date Fair Value Per Award
Non-vested as of December 31, 2021493,513 $141.98 6,000 $172.11 
    Granted78,236 $115.91 26,173 $100.97 
     Vested(114,991)$90.57 — $— 
     Forfeited(14,239)$91.17 (243)$127.09 
Non-vested as of December 31, 2022442,519 $152.36 31,930 $114.14